ישראל - עברית - Ministry of Health

kamada ltd, israel - beclometasone dipropionate; formoterol fumarate dihydrate; glycopyrronium as bromide - glycopyrronium as bromide 9 mcg/delivered dose; formoterol fumarate dihydrate 5.2 mcg/delivered dose; beclometasone dipropionate 87.4 mcg/delivered dose - formoterol, glycopyrronium bromide and beclometasone

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - budesonide; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - formoterol fumarate dihydrate 4.5 mcg/actuation; budesonide 160 mcg/actuation - formoterol and budesonide

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - aclidinium as bromide; formoterol fumarate dihydrate - אבקה לשאיפה - formoterol fumarate dihydrate 11.8 mcg; aclidinium as bromide 340 mcg - aclidinium bromide

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - budesonide; formoterol fumarate dihydrate; glycopyrronium - תרחיף לשאיפה - formoterol fumarate dihydrate 5 mcg; glycopyrronium 7.2 mcg; budesonide 160 mcg - budesonide

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - budesonide; formoterol fumarate dihydrate - אבקה לשאיפה - budesonide 100 mcg/dose; formoterol fumarate dihydrate 6 mcg/dose - formoterol and budesonide

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - budesonide; formoterol fumarate dihydrate - אבקה לשאיפה - budesonide 200 mcg/dose; formoterol fumarate dihydrate 6 mcg/dose - formoterol and budesonide

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - budesonide; formoterol fumarate dihydrate - אבקה לשאיפה - budesonide 400 mcg/dose; formoterol fumarate dihydrate 12 mcg/dose - formoterol and budesonide

ישראל - עברית - Ministry of Health

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.05 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.125 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.25 mg/dose; formoterol fumarate dihydrate 0.01 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.